Teilnehmerinnen und Teilnehmer diskutierten Fragen rund um die Translation von Grundlagenforschung in klinische Anwendung. Das Symposium "Translating Basic Research into Clinical Application" bot insgesamt 24 Vorträge in sechs verschiedenen Sessions, am 8. Oktober hielt Ruedi Aebersold von der Eidgenössisch-Technischen Hochschule in Zürich (ETH) die Keynote Lecture zum Thema "Genotypic variability and the quantitative proteotype".
Kurzer Bericht von Dr. Michael Hinz (MDC):
On 8-9 October 2015, the first BIH Young Science Symposium took place at the venue of the Kaiserin-Friedrich Foundation in Berlin-Mitte. Scientific Organizers were Michael Hinz, Uta Höpken (both MDC) and Michael Schumann (Charité). Group Leaders from the MDC discussed, together with clinical scientists from the Charité and international guests such as Ruedi Aebersold (ETH, Zurich) or Amanda Fisher (MRC Clinical Science Centre, London), how basic research can be translated into clinical application. A series of new methods and unpublished data were presented, addressing different topics of systems medicine, such as global gene expression control, single-cell gene expression analysis, tissue engineering, quantitative proteomics, microbiome-based diagnostics or the interplay between inflammation and cancer. The speakers and all other participants created an inspiring atmosphere with vivid discussions, which might foster new interactions of basic and clinical scientists in Berlin and beyond.